STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more

STAT November 11, 2024
Ed Silverman

Pfizer plans to pump $1 billion into its operations in China

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online meetings, calls, and deadlines has, once again, returned. But what can you do? The world, such as it is, continues to spin. So why not give it a nudge in a better direction with a cup of stimulation. Our choice today is pistachio creme. Meanwhile, here are a few items of interest to help get you on your way. We hope today is manageable and productive. Best of luck, and keep in touch. …

GSK plans to depart the biotechnology industry’s largest trade group,...

Today's Sponsors

Today's Sponsor